Blepharoptosis clinical trials

Explore recruiting blepharoptosis clinical trials.

Recruiting blepharoptosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Blepharoptosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomised, Double-Masked, Placebo-Controlled Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops) used twice daily (BID) in the Treatment of Acquired Blepharoptosis

Hungary, Germany, Spain, Italy, France, Czechia +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Blepharoptosis trials by city

Blepharoptosis in Toronto Blepharoptosis in Vancouver Blepharoptosis in Montreal Blepharoptosis in Calgary Blepharoptosis in Edmonton Blepharoptosis in Ottawa Blepharoptosis in Winnipeg Blepharoptosis in Quebec City Blepharoptosis in Hamilton Blepharoptosis in Kitchener Blepharoptosis in London Blepharoptosis in Halifax Blepharoptosis in New York Blepharoptosis in Los Angeles Blepharoptosis in Chicago Blepharoptosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease